sulfadiazine has been researched along with Central Nervous System Toxoplasmosis in 97 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The preferred therapeutic regimen for Toxoplasma encephalitis (TE) is a combination of pyrimethamine and sulfadiazine, and trimethoprim-sulfamethoxazole (TMP-SMX) plus azithromycin is the widespread alternative therapeutic regimen." | 9.51 | Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial. ( Chen, H; Chen, Y; He, X; Huang, Y; Li, Y; Lu, Y; Wu, Y; Zeng, Y; Zhang, W, 2022) |
| "An open, randomised, multicentre trial was conducted to evaluate the efficacy of thrice-weekly versus daily therapy with sulfadiazine-pyrimethamine in the prevention of relapses of toxoplasmic encephalitis in HIV-infected patients." | 9.09 | Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. ( Arrizabalaga, J; Cosin, J; Cruceta, A; Domingo, P; Fariñas, MC; Ferrer, E; Gatell, JM; Gudiol, F; Knobel, H; Leyes, M; Martínez-Lacasa, J; Miró, JM; Podzamczer, D; Polo, R; Ramón, JM; Ribera, E; Sirera, G, 2000) |
| "To evaluate the efficacy and tolerance of atovaquone used as long-term maintenance therapy in patients with toxoplasmic encephalitis and intolerant of conventional anti-Toxoplasma therapies." | 9.08 | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. ( Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F, 1996) |
| "Between February 1990 and June 1993, 105 patients with HIV infection were enrolled after each had had resolution of an acute episode of toxoplasmic encephalitis treated with sulfadiazine (1 g four times per day) plus pyrimethamine (50 mg/d) plus folinic acid (15 mg/d) for 4 to 8 weeks." | 9.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "This European multicenter study compares the efficacy and tolerance of the combination of pyrimethamine-clindamycin (Pyr-Cm) with the standard therapy pyrimethamine-sulfadiazine (Pyr-Sdz) for the treatment of toxoplasmic encephalitis (TE) in patients with AIDS." | 9.08 | Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. ( Clumeck, N; De Wit, S; Katlama, C; O'Doherty, E; Van Glabeke, M, 1996) |
| "A prospective study was conducted to evaluate azithromycin in combination with pyrimethamine for treatment of acute Toxoplasma encephalitis in patients with AIDS." | 9.07 | Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. ( Hazebroucq, V; Joly, V; Leport, C; Morlat, P; Raffi, F; Saba, J; Vildé, JL, 1993) |
| "To compare pyrimethamine plus clindamycin (PC) to pyrimethamine plus sulfadiazine (PS) as a treatment for toxoplasmic encephalitis (TE) in patients with the acquired immunodeficiency syndrome (AIDS)." | 9.07 | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Clumeck, N; Dannemann, B; Israelski, D; Leport, C; Luft, B; McCutchan, JA; Morlat, P; Nussbaum, J, 1992) |
| " The standard treatment for toxoplasmic encephalitis is pyrimethamine and sulfadiazine." | 7.71 | Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia. ( Chen, ER; Chen, YS; Huang, CK; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, HC, 2002) |
| "The effectiveness of combinations of rifabutin with atovaquone, clindamycin, pyrimethamine, or sulfadiazine in the treatment of toxoplasmic encephalitis in a murine model was investigated." | 7.69 | Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice. ( Araujo, FG; Remington, JS; Suzuki, Y, 1996) |
| "Patients with AIDS and Toxoplasma encephalitis may have several predisposing conditions that can lead to the development of sulfadiazine-induced crystalluria, including poor fluid intake, fever, diarrhea, and hypoalbuminemia, in addition to the high doses of the drug required and the prolonged period of treatment." | 7.69 | Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis. ( Collazos, J; Díaz, F; Martínez, E; Mayo, J, 1996) |
| "The preferred therapeutic regimen for Toxoplasma encephalitis (TE) is a combination of pyrimethamine and sulfadiazine, and trimethoprim-sulfamethoxazole (TMP-SMX) plus azithromycin is the widespread alternative therapeutic regimen." | 5.51 | Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial. ( Chen, H; Chen, Y; He, X; Huang, Y; Li, Y; Lu, Y; Wu, Y; Zeng, Y; Zhang, W, 2022) |
| "An open, randomised, multicentre trial was conducted to evaluate the efficacy of thrice-weekly versus daily therapy with sulfadiazine-pyrimethamine in the prevention of relapses of toxoplasmic encephalitis in HIV-infected patients." | 5.09 | Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group. ( Arrizabalaga, J; Cosin, J; Cruceta, A; Domingo, P; Fariñas, MC; Ferrer, E; Gatell, JM; Gudiol, F; Knobel, H; Leyes, M; Martínez-Lacasa, J; Miró, JM; Podzamczer, D; Polo, R; Ramón, JM; Ribera, E; Sirera, G, 2000) |
| "To evaluate the efficacy and tolerance of atovaquone used as long-term maintenance therapy in patients with toxoplasmic encephalitis and intolerant of conventional anti-Toxoplasma therapies." | 5.08 | Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. ( Gourdon, D; Katlama, C; Lapierre, D; Mouthon, B; Rousseau, F, 1996) |
| "Between February 1990 and June 1993, 105 patients with HIV infection were enrolled after each had had resolution of an acute episode of toxoplasmic encephalitis treated with sulfadiazine (1 g four times per day) plus pyrimethamine (50 mg/d) plus folinic acid (15 mg/d) for 4 to 8 weeks." | 5.08 | Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group. ( Bolao, F; Cosín, J; Domingo, P; Gatell, JM; Laguna, F; Miró, JM; Podzamczer, D; Santamaría, J; Sirera, G; Verdejo, J, 1995) |
| "This European multicenter study compares the efficacy and tolerance of the combination of pyrimethamine-clindamycin (Pyr-Cm) with the standard therapy pyrimethamine-sulfadiazine (Pyr-Sdz) for the treatment of toxoplasmic encephalitis (TE) in patients with AIDS." | 5.08 | Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. ( Clumeck, N; De Wit, S; Katlama, C; O'Doherty, E; Van Glabeke, M, 1996) |
| "To compare pyrimethamine plus clindamycin (PC) to pyrimethamine plus sulfadiazine (PS) as a treatment for toxoplasmic encephalitis (TE) in patients with the acquired immunodeficiency syndrome (AIDS)." | 5.07 | Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group. ( Antoniskis, D; Chiu, J; Clumeck, N; Dannemann, B; Israelski, D; Leport, C; Luft, B; McCutchan, JA; Morlat, P; Nussbaum, J, 1992) |
| "A prospective study was conducted to evaluate azithromycin in combination with pyrimethamine for treatment of acute Toxoplasma encephalitis in patients with AIDS." | 5.07 | Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. ( Hazebroucq, V; Joly, V; Leport, C; Morlat, P; Raffi, F; Saba, J; Vildé, JL, 1993) |
| " The standard treatment for toxoplasmic encephalitis is pyrimethamine and sulfadiazine." | 3.71 | Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia. ( Chen, ER; Chen, YS; Huang, CK; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, HC, 2002) |
| "In 26 AIDS patients treated for toxoplasmic encephalitis, the inhibitory effect on Toxoxplasma growth of sequential sera taken before and after initiation of therapy was determined using a culture-based immunoassay and compared with pyrimethamine blood levels." | 3.70 | Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis. ( Derouin, F; Farinotti, R; Gérard, L; Leport, C; Maslo, C, 1998) |
| "The effectiveness of combinations of rifabutin with atovaquone, clindamycin, pyrimethamine, or sulfadiazine in the treatment of toxoplasmic encephalitis in a murine model was investigated." | 3.69 | Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice. ( Araujo, FG; Remington, JS; Suzuki, Y, 1996) |
| "Patients with AIDS and Toxoplasma encephalitis may have several predisposing conditions that can lead to the development of sulfadiazine-induced crystalluria, including poor fluid intake, fever, diarrhea, and hypoalbuminemia, in addition to the high doses of the drug required and the prolonged period of treatment." | 3.69 | Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis. ( Collazos, J; Díaz, F; Martínez, E; Mayo, J, 1996) |
| "11), and drug discontinuation because of adverse events (P-C: RR 0." | 2.55 | A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option? ( Benites-Zapata, VA; Deshpande, A; Hernandez, AV; Pasupuleti, V; Pellegrino, D; Penalva de Oliveira, AC; Thota, P; Vidal, JE, 2017) |
| " Dosage must be adjusted to the results of blood counts." | 2.38 | [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients]. ( Leport, C; Niyongabo, T; Vildé, JL, 1991) |
| "The simultaneous occurrence of cerebral toxoplasmosis and cryptococcosis is rare." | 1.91 | A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome. ( Panda, BK; Purandare, B; Rege, S; Suryawanshi, VR, 2023) |
| "This study showed that a 10-day treatment with 20 mg/kg of fluconazole combined with sulfadiazine and pyrimethamine 1." | 1.62 | Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine. ( Anita, M; Hadi, M; Mohammad, JM; Reza, S; Sina, S; Soudabeh, E, 2021) |
| "The current standard treatment for cerebral toxoplasmosis (pyrimethamine/sulfadiazine) often encounters problems of poor tolerability, adverse effects, frequent dropouts and non-availability of pyrimethamine/sulfadiazine in some parts of India." | 1.42 | Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting. ( Goswami, RP; Rahman, M; Ray, Y; Tripathi, SK, 2015) |
| "Severe forms of cerebral toxoplasmosis in patients with HIV infection are characterized by a good prognosis in approximately 50% of cases." | 1.38 | Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis. ( Ait Hssain, A; Bouadma, L; da Silva, D; Klein, IF; Messika, J; Mourvillier, B; Schmidt, M; Sonneville, R; Wolff, M, 2012) |
| "The retrieved renal calculi were negative for the common stones that are routinely tested for in our laboratory and had the macroscopic characteristics of a sulphadiazine stone." | 1.38 | Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis. ( Hew, M; McGettigan, BD; McLean-Tooke, A; Phillips, E, 2012) |
| "Sulfadiazine was withdrawn after 14-21 days to allow reactivation." | 1.34 | The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice. ( Jost, C; Liesenfeld, O; Reiter-Owona, I, 2007) |
| "Atovaquone was detectable in sera, brains, livers, and lungs of infected mice by high-performance liquid chromatography and/or mass spectrometry." | 1.32 | Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis. ( Arasteh, K; Borner, K; Bushrab, FN; Dunay, IR; Fitzner, R; Heimesaat, MM; Kurowski, M; Liesenfeld, O; Müller, RH; Stocker, H, 2004) |
| "Six patients had cerebral toxoplasmosis diagnosed on the basis of neurological signs and observation of the patients' mental confusion, seizures, and typical lesions (which were assessed by computed tomography, magnetic resonance imaging, or both)." | 1.31 | Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. ( Basara, N; Bischoff, M; Blau, IW; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Roemer, E; Sanchez, H; Wocker, EL, 2001) |
| "Neurotoxoplasmosis was the most frequent presenting symptom of AIDS (53." | 1.30 | [Cerebral toxoplasmosis and AIDS in Martinique]. ( Bourée, P; Dumazedier, D; Magdeleine, C; Sobesky, G, 1997) |
| "Cerebral toxoplasmosis is a rare late complication in allogeneic bone marrow transplanted patients." | 1.30 | Post-transplant cerebral toxoplasmosis diagnosed by magnetic resonance imaging. ( De Rosa, G; Di Salle, F; Pezzullo, L; Picardi, M; Raiola, A; Rotoli, B, 1998) |
| "In particular, in patients with AIDS who are more susceptible for adverse drug reactions and who are simultaneously receiving a variety of drugs with a considerable potential of cutaneous side effects, therapy cannot be withhold for lack of therapeutic alternatives." | 1.29 | [Drug-induced Stevens-Johnson syndrome in a patient with AIDS]. ( Bircher, A; Haefeli, WE; Leib, SL; Lüscher, TF; Schlienger, RG, 1993) |
| "A pregnant woman was diagnosed with central nervous system toxoplasmosis and human immunodeficiency virus infection." | 1.29 | Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report. ( Brown, GM; Hedriana, HL; Mitchell, JL; Williams, SB, 1993) |
| "Cerebral toxoplasmosis is the most common opportunistic infection of the central nervous system in AIDS patients." | 1.29 | [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone]. ( Cardenal, C; Gatell, JM; Guelar, A; Mallolas, J; Miró, JM; Soriano, E; Zamora, L, 1994) |
| "Three of 50 (6%) had hemichoreoathetosis." | 1.29 | Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis. ( Andreula, C; Angarano, G; Armenise, S; De Blasi, R; de Mari, M; Maggi, P; Romanelli, C; Zimatore, G, 1996) |
| "Sulfadiazine-nephropathy and -nephrolithiasis were well known complications of high dose sulfadiazine therapy 50 years ago." | 1.29 | [Sulfadiazine nephrolithiasis and nephropathy]. ( Furrer, H; Hess, B; Jaeger, P; von Overbeck, J, 1994) |
| "Ten (91%) of these 11 patients with recurrence showed focal persistent enhancement after the initial treatment of toxoplasmosis abscess." | 1.29 | Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence. ( Benmelha, Z; Bouvet, E; Casalino, E; Laissy, JP; Lariven, S; Parlier, C; Servois, V; Sibert, A; Soyer, P; Vachon, F, 1994) |
| "The survival from AIDS or CD4 count = 50 cells/mm3 did not differ significantly between those with treated CTOX and a control group who had no toxoplasma infection, suggesting that treatment is reasonably effective." | 1.29 | Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients. ( Brettle, RP; Burns, SM; Flegg, PJ; Laing, RB; Leen, CL, 1996) |
| "Sulphadiazine-induced crystalluria and acute renal failure is increasingly frequent." | 1.29 | Acute renal failure due to sulphadiazine crystalluria in AIDS patients. ( Abad, J; Albalate, M; Caramelo, C; Casado, S; de Sequera, P; Fernández Guerrero, M; Hernandez, J; Ortiz, A; Ramiro, E; Vazquez, A, 1996) |
| "Treatment with pyrimethamine plus sulfadiazine produced clinical cures in 100% of the infected mice 1 month after infection." | 1.29 | A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii. ( Arribas, JR; de Diego, JA; Penin, P; Vázquez, E; Vázquez, JJ, 1996) |
| "ET was the AIDS-defining condition in 44% of the patients." | 1.29 | [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients]. ( Barrio, JL; Cadafalch, J; Domingo, P; Ferrer, S; Fuentes, I; Fuster, M; Iranzo, A; Muñoz, C; Nolla, J; Ris, J; Sambeat, MA, 1996) |
| "Cerebral toxoplasmosis is optimally treated with the combination of high doses of sulphadiazine and pyrimethamine." | 1.29 | Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosis. ( Echevarría, S; Fariñas, MC; González, A; González-Macías, J; Pérez del Molino, A; Sampedro, I, 1993) |
| "One complication of this is acute renal failure secondary to sulphadiazine-induced crystalluria." | 1.29 | Renal ultrasonic findings in sulphadiazine-induced renal failure. ( Kane, D; Keating, S; Mulcahy, FM; Murphy, JM; Wilson, GF, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 65 (67.01) | 18.2507 |
| 2000's | 14 (14.43) | 29.6817 |
| 2010's | 12 (12.37) | 24.3611 |
| 2020's | 6 (6.19) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, J | 1 |
| Kuppachi, S | 1 |
| Huffman, AM | 1 |
| Ayariga, JA | 1 |
| Napier, A | 1 |
| Robertson, BK | 1 |
| Abugri, DA | 1 |
| Suryawanshi, VR | 1 |
| Purandare, B | 1 |
| Rege, S | 1 |
| Panda, BK | 1 |
| Li, Y | 2 |
| Zeng, Y | 1 |
| Lu, Y | 1 |
| He, X | 1 |
| Wu, Y | 1 |
| Zhang, W | 1 |
| Huang, Y | 1 |
| Chen, H | 1 |
| Chen, Y | 1 |
| Zeng, YM | 1 |
| Lu, YQ | 1 |
| Qin, YY | 1 |
| Chen, YK | 1 |
| Sina, S | 1 |
| Mohammad, JM | 1 |
| Reza, S | 1 |
| Anita, M | 1 |
| Soudabeh, E | 1 |
| Hadi, M | 1 |
| Bejjanki, H | 1 |
| Olaoye, OA | 1 |
| Santos, AH | 1 |
| Koratala, A | 1 |
| Le Clech, L | 1 |
| Hutin, P | 1 |
| Le Gal, S | 1 |
| Guillerm, G | 1 |
| Olmos Soto, S | 1 |
| Reus Bañuls, S | 1 |
| Mora Castera, E | 1 |
| Villarubia Lor, MB | 1 |
| Goswami, RP | 2 |
| Rahman, M | 1 |
| Ray, Y | 1 |
| Tripathi, SK | 1 |
| Miyagi, T | 1 |
| Itonaga, H | 1 |
| Aosai, F | 1 |
| Taguchi, J | 1 |
| Norose, K | 1 |
| Mochizuki, K | 1 |
| Fujii, H | 1 |
| Furumoto, A | 1 |
| Ohama, M | 1 |
| Karimata, K | 1 |
| Yamanoha, A | 1 |
| Taniguchi, H | 1 |
| Sato, S | 1 |
| Taira, N | 1 |
| Moriuchi, Y | 1 |
| Fukushima, T | 1 |
| Masuzaki, H | 1 |
| Miyazaki, Y | 1 |
| Hernandez, AV | 1 |
| Thota, P | 1 |
| Pellegrino, D | 1 |
| Pasupuleti, V | 1 |
| Benites-Zapata, VA | 1 |
| Deshpande, A | 1 |
| Penalva de Oliveira, AC | 1 |
| Vidal, JE | 1 |
| Faucher, B | 1 |
| Moreau, J | 1 |
| Zaegel, O | 1 |
| Franck, J | 1 |
| Piarroux, R | 1 |
| Diz, S | 1 |
| Barbolla, I | 1 |
| Egea, M | 1 |
| de Luna, G | 1 |
| Allinson, J | 1 |
| Topping, W | 1 |
| Edwards, SG | 1 |
| Miller, RF | 1 |
| Kanno, A | 1 |
| Suzuki, Y | 2 |
| Minami, M | 1 |
| Ogawa, K | 1 |
| Oishi, M | 1 |
| Kamei, S | 1 |
| McGettigan, BD | 1 |
| Hew, M | 1 |
| Phillips, E | 1 |
| McLean-Tooke, A | 1 |
| Sonneville, R | 1 |
| Schmidt, M | 1 |
| Messika, J | 1 |
| Ait Hssain, A | 1 |
| da Silva, D | 1 |
| Klein, IF | 1 |
| Bouadma, L | 1 |
| Wolff, M | 1 |
| Mourvillier, B | 1 |
| Ball, SC | 1 |
| Tsai, HC | 1 |
| Lee, SS | 1 |
| Lin, HH | 1 |
| Lin, WR | 1 |
| Chen, YS | 1 |
| Huang, CK | 1 |
| Liu, YC | 1 |
| Chen, ER | 1 |
| Lee, SA | 1 |
| James, CW | 1 |
| Szabo, S | 1 |
| Dressler, RM | 1 |
| Dunay, IR | 1 |
| Heimesaat, MM | 1 |
| Bushrab, FN | 1 |
| Müller, RH | 1 |
| Stocker, H | 1 |
| Arasteh, K | 1 |
| Kurowski, M | 1 |
| Fitzner, R | 1 |
| Borner, K | 1 |
| Liesenfeld, O | 2 |
| Holtkamp, M | 1 |
| Okuducu, AF | 1 |
| Klingebiel, R | 1 |
| Ploner, CJ | 1 |
| Di Carlo, P | 1 |
| Mazzola, A | 1 |
| Romano, A | 1 |
| Schimmenti, MG | 1 |
| Colicchia, P | 1 |
| Bellipanni, P | 1 |
| Titone, L | 1 |
| Solano Remírez, M | 1 |
| Oliván Ballabriga, AS | 1 |
| da Costa Rodríguez, GM | 1 |
| Alvarez Frías, MT | 1 |
| González Arencibia, C | 1 |
| Schuler, AK | 1 |
| Talor, Z | 1 |
| Jost, C | 1 |
| Reiter-Owona, I | 1 |
| de la Prada Alvarez, FJ | 1 |
| Prados Gallardo, AM | 1 |
| Tugores Vázquez, A | 1 |
| Uriol Rivera, M | 1 |
| Morey Molina, A | 1 |
| Arens, J | 1 |
| Barnes, K | 1 |
| Crowley, N | 1 |
| Maartens, G | 1 |
| Winstanley, P | 1 |
| Podzamczer, D | 2 |
| Miró, JM | 3 |
| Bolao, F | 1 |
| Gatell, JM | 3 |
| Cosín, J | 2 |
| Sirera, G | 2 |
| Domingo, P | 3 |
| Laguna, F | 1 |
| Santamaría, J | 1 |
| Verdejo, J | 1 |
| Kovacs, JA | 1 |
| Langmann, P | 1 |
| Klinker, H | 1 |
| Richter, E | 1 |
| Huber, W | 1 |
| Bautz, W | 1 |
| Classen, M | 1 |
| Schepp, W | 1 |
| Potter, JL | 1 |
| Kofron, WG | 1 |
| Laissy, JP | 1 |
| Soyer, P | 1 |
| Parlier, C | 1 |
| Lariven, S | 1 |
| Benmelha, Z | 1 |
| Servois, V | 1 |
| Casalino, E | 1 |
| Bouvet, E | 1 |
| Sibert, A | 1 |
| Vachon, F | 1 |
| Fernandez, JM | 1 |
| Sadaba, F | 1 |
| Villaverde, FJ | 1 |
| Alvaro, LC | 1 |
| Cortina, C | 1 |
| Marques, LP | 1 |
| Madeira, EP | 1 |
| Santos, OR | 1 |
| Furrer, H | 1 |
| von Overbeck, J | 1 |
| Jaeger, P | 1 |
| Hess, B | 1 |
| Oksenhendler, E | 1 |
| Charreau, I | 1 |
| Tournerie, C | 1 |
| Azihary, M | 1 |
| Carbon, C | 1 |
| Aboulker, JP | 1 |
| Guelar, A | 1 |
| Mallolas, J | 1 |
| Zamora, L | 1 |
| Cardenal, C | 1 |
| Soriano, E | 1 |
| McAuley, J | 1 |
| Boyer, KM | 2 |
| Patel, D | 1 |
| Mets, M | 1 |
| Swisher, C | 1 |
| Roizen, N | 1 |
| Wolters, C | 1 |
| Stein, L | 1 |
| Stein, M | 1 |
| Schey, W | 1 |
| Walckenaer, G | 1 |
| Leport, C | 5 |
| Longuet, P | 1 |
| Perronne, C | 1 |
| Lacassin, F | 1 |
| Vildé, JL | 3 |
| Saba, J | 1 |
| Morlat, P | 3 |
| Raffi, F | 1 |
| Hazebroucq, V | 1 |
| Joly, V | 1 |
| Araujo, FG | 3 |
| Slifer, T | 2 |
| Remington, JS | 3 |
| Kronawitter, U | 1 |
| Jakob, K | 1 |
| Zoller, WG | 1 |
| Rauh, G | 1 |
| Goebel, FD | 1 |
| McCabe, R | 1 |
| Chirurgi, V | 1 |
| Hedriana, HL | 1 |
| Mitchell, JL | 1 |
| Brown, GM | 1 |
| Williams, SB | 1 |
| Schlienger, RG | 1 |
| Haefeli, WE | 1 |
| Bircher, A | 1 |
| Leib, SL | 1 |
| Lüscher, TF | 1 |
| Ragnaud, JM | 1 |
| Dupon, M | 1 |
| Lacoste, D | 1 |
| Pellegrin, JL | 1 |
| Chene, G | 1 |
| Desguerre, I | 1 |
| Pedespan, JM | 1 |
| Buissonnière, R | 1 |
| Couvreur, J | 1 |
| Ponsot, G | 1 |
| Nath, A | 1 |
| Hobson, DE | 1 |
| Russell, A | 1 |
| Fariñas, MC | 3 |
| Echevarría, S | 1 |
| Sampedro, I | 1 |
| González, A | 1 |
| Pérez del Molino, A | 1 |
| González-Macías, J | 2 |
| Murray-Pulsifer, K | 1 |
| Hein, R | 1 |
| Brunkhorst, R | 1 |
| Thon, WF | 1 |
| Schedel, I | 1 |
| Schmidt, RE | 1 |
| Caumes, E | 1 |
| Bocquet, H | 1 |
| Guermonprez, G | 1 |
| Rogeaux, O | 1 |
| Bricaire, F | 1 |
| Katlama, C | 3 |
| Gentilini, M | 1 |
| Van Delden, C | 1 |
| Hirschel, B | 1 |
| Patel, DV | 1 |
| Holfels, EM | 1 |
| Vogel, NP | 1 |
| Mets, MB | 1 |
| Swisher, CN | 1 |
| Roizen, NJ | 1 |
| Stein, LK | 1 |
| Stein, MA | 1 |
| Hopkins, J | 1 |
| Withers, SE | 1 |
| Mack, DG | 1 |
| Luciano, RA | 1 |
| Meier, P | 1 |
| McLeod, RL | 1 |
| Ferrer, S | 1 |
| Fuentes, I | 1 |
| Muñoz, C | 1 |
| Iranzo, A | 1 |
| Barrio, JL | 1 |
| Fuster, M | 1 |
| Ris, J | 1 |
| Sambeat, MA | 1 |
| Cadafalch, J | 1 |
| Nolla, J | 1 |
| Rodríguez-Carballeira, M | 1 |
| Casagran, A | 1 |
| Moré, J | 1 |
| Argilaga, R | 1 |
| García, M | 1 |
| Wei, ME | 1 |
| Campbell, SH | 1 |
| Taylor, C | 1 |
| Díaz, F | 1 |
| Collazos, J | 1 |
| Mayo, J | 1 |
| Martínez, E | 1 |
| Maggi, P | 1 |
| de Mari, M | 1 |
| De Blasi, R | 1 |
| Armenise, S | 1 |
| Romanelli, C | 1 |
| Andreula, C | 1 |
| Zimatore, G | 1 |
| Angarano, G | 1 |
| De Wit, S | 1 |
| O'Doherty, E | 1 |
| Van Glabeke, M | 1 |
| Clumeck, N | 2 |
| Mouthon, B | 1 |
| Gourdon, D | 1 |
| Lapierre, D | 1 |
| Rousseau, F | 1 |
| Laing, RB | 1 |
| Flegg, PJ | 1 |
| Brettle, RP | 1 |
| Leen, CL | 1 |
| Burns, SM | 1 |
| de Sequera, P | 1 |
| Albalate, M | 1 |
| Hernandez, J | 1 |
| Vazquez, A | 1 |
| Abad, J | 1 |
| Ramiro, E | 1 |
| Fernández Guerrero, M | 1 |
| Caramelo, C | 1 |
| Casado, S | 1 |
| Ortiz, A | 1 |
| Kane, D | 1 |
| Murphy, JM | 1 |
| Keating, S | 1 |
| Wilson, GF | 1 |
| Mulcahy, FM | 1 |
| de Diego, JA | 1 |
| Penin, P | 1 |
| Arribas, JR | 1 |
| Vázquez, E | 1 |
| Vázquez, JJ | 1 |
| Hoetelmans, RM | 1 |
| Kraaijeveld, CL | 1 |
| Meenhorst, PL | 1 |
| Mulder, JW | 1 |
| Burger, DM | 1 |
| Koks, CH | 1 |
| Beijnen, JH | 1 |
| de Luis, DA | 1 |
| Fortun, J | 1 |
| Pintado, V | 1 |
| Aller de la Fuente, R | 1 |
| Supiot, F | 1 |
| Guillaume, MP | 1 |
| Hermanus, N | 1 |
| Telerman-Toppet, N | 1 |
| Karmali, R | 1 |
| Bourée, P | 1 |
| Dumazedier, D | 1 |
| Magdeleine, C | 1 |
| Sobesky, G | 1 |
| Sillevis Smitt, P | 1 |
| Swaak, T | 1 |
| Brinkman, K | 1 |
| Debast, S | 1 |
| Sauerwein, R | 1 |
| Ooyman, F | 1 |
| Hiel, J | 1 |
| Raemaekers, J | 1 |
| Campany, D | 1 |
| Sales, P | 1 |
| Grau, S | 1 |
| Saballs, P | 1 |
| Drobnic, L | 1 |
| Gimeno, JL | 1 |
| Arjol, AM | 1 |
| Sánchez, C | 1 |
| Dalmau, D | 1 |
| Picardi, M | 1 |
| De Rosa, G | 1 |
| Di Salle, F | 1 |
| Pezzullo, L | 1 |
| Raiola, A | 1 |
| Rotoli, B | 1 |
| Derouin, F | 1 |
| Gérard, L | 1 |
| Farinotti, R | 1 |
| Maslo, C | 2 |
| Carrión-Carrión, C | 1 |
| Morales-Suárez-Varela, MM | 1 |
| Llopis-González, A | 1 |
| Colebunders, R | 1 |
| Depraetere, K | 1 |
| De Droogh, E | 1 |
| Kamper, A | 1 |
| Corthout, B | 1 |
| Bottiau, E | 1 |
| Ferrer, E | 1 |
| Ramón, JM | 1 |
| Ribera, E | 1 |
| Cruceta, A | 1 |
| Knobel, H | 1 |
| Polo, R | 1 |
| Leyes, M | 1 |
| Arrizabalaga, J | 2 |
| Martínez-Lacasa, J | 1 |
| Gudiol, F | 1 |
| Roemer, E | 1 |
| Blau, IW | 1 |
| Basara, N | 1 |
| Kiehl, MG | 1 |
| Bischoff, M | 1 |
| Günzelmann, S | 1 |
| Kirsten, D | 1 |
| Sanchez, H | 1 |
| Wocker, EL | 1 |
| Fauser, AA | 1 |
| Fernández-Ayala, M | 1 |
| Nan, D | 1 |
| Kupila, L | 1 |
| Sonninen, V | 1 |
| Peltonen, R | 1 |
| Uksila, J | 1 |
| Hukkanen, V | 1 |
| Kotilainen, P | 1 |
| Iribarren, JA | 1 |
| Garde, C | 1 |
| Rodriguez-Arrondo, F | 1 |
| Blanco, A | 1 |
| Reboli, AC | 1 |
| Mandler, HD | 1 |
| De Jaureguiberry, JP | 1 |
| Reboul, P | 1 |
| Vey, N | 1 |
| Jaubert, D | 1 |
| Lüscher, C | 1 |
| Horber, FF | 1 |
| Iannucci, AA | 1 |
| Hart, LL | 1 |
| Corbella, X | 1 |
| Mascaró, J | 1 |
| Santín, M | 1 |
| Carratalà, J | 1 |
| Dannemann, B | 1 |
| McCutchan, JA | 1 |
| Israelski, D | 1 |
| Antoniskis, D | 1 |
| Luft, B | 1 |
| Nussbaum, J | 1 |
| Chiu, J | 1 |
| de Gans, J | 1 |
| Portegies, P | 1 |
| Reiss, P | 1 |
| Troost, D | 1 |
| van Gool, T | 1 |
| Lange, JM | 1 |
| Fégueux, S | 1 |
| De Truchis, P | 1 |
| Balloul, H | 1 |
| Matheron, S | 1 |
| Coulaud, JP | 1 |
| Niyongabo, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Dose-Escalation, Phase I/II Study of Oral Azithromycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS[NCT00000966] | Phase 1 | 45 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for sulfadiazine and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Successful treatment of toxoplasmic encephalitis diagnosed early by polymerase chain reaction after allogeneic hematopoietic stem cell transplantation: two case reports and review of the literature.
Topics: Adult; Antiprotozoal Agents; Drug Therapy, Combination; Early Diagnosis; Hematopoietic Stem Cell Tra | 2015 |
A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
Topics: Adult; Antiprotozoal Agents; Clindamycin; Cohort Studies; Female; HIV Infections; Humans; Male; Midd | 2017 |
[Acute kidney failure caused by sulfadiazine stones. A complication of the therapy of toxoplasmosis in AIDS].
Topics: Acute Kidney Injury; AIDS-Related Opportunistic Infections; Clindamycin; Drug Therapy, Combination; | 1993 |
Issues in toxoplasmosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Clindamycin; Drug Therapy, Combination; Encephalitis | 1993 |
Movement disorders with cerebral toxoplasmosis and AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Basal Ganglia Diseases; Cerebral Cortex; Chorea; Drug | 1993 |
Clindamycin in the treatment of toxoplasmosis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Humans; Pyrimethamine; Retrospective Studies; Sulfa | 1992 |
[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Drug Therapy, Combination; Folic Acid; Hematologic Diseases; Hum | 1991 |
9 trials available for sulfadiazine and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Synergistic sulfonamides plus clindamycin as an alternative therapeutic regimen for HIV-associated Toxoplasma encephalitis: a randomized controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clindamycin; Encephalitis; Humans; Sulfadiazine; S | 2022 |
A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-I | 2020 |
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Drug Administration Schedule; Drug Therapy, Comb | 1995 |
Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial.
Topics: Animals; Calcinosis; Chemistry, Pharmaceutical; Child; Child, Preschool; Drug Administration Schedul | 1994 |
Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Azithromycin; Drug Administration Sched | 1993 |
Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clindamycin; Drug Therapy, Comb | 1996 |
Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Atovaquone; Clindamycin; Encephalit | 1996 |
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Combination; Encep | 2000 |
Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. The California Collaborative Treatment Group.
Topics: Acquired Immunodeficiency Syndrome; Adult; Clindamycin; Drug Evaluation; Drug Therapy, Combination; | 1992 |
81 other studies available for sulfadiazine and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
AKI in a Patient with Cerebral Toxoplasmosis.
Topics: Acute Kidney Injury; Humans; Sulfadiazine; Toxoplasmosis, Cerebral; Ureteral Calculi | 2020 |
Inhibition of
Topics: Antiparasitic Agents; Humans; Quinidine; Sulfadiazine; Toxoplasma; Toxoplasmosis, Cerebral | 2022 |
A Case of Cerebral Toxoplasmosis and Cryptococcosis Preferred Therapy Associated Adverse Drug Reactions in a Patient Newly Co-diagnosed with Acquired Immune Deficiency Syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococ | 2023 |
Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine.
Topics: 14-alpha Demethylase Inhibitors; Acute Disease; Animals; Antiprotozoal Agents; Brain; Disease Models | 2021 |
Liver transplant, toxoplasmosis and kidney stones: connecting the dots.
Topics: Aftercare; Antimalarials; Antiprotozoal Agents; Atovaquone; Brain; Brain Edema; Female; Humans; Kidn | 2019 |
Skin nodules in a patient with acute lymphoblastic leukaemia.
Topics: Adolescent; Amphotericin B; Cord Blood Stem Cell Transplantation; Dermatomycoses; Diagnosis, Differe | 2014 |
[Cerebral toxoplasmosis in a patient with Waldenström's macroglobulinemia].
Topics: Aged; Antiprotozoal Agents; Biopsy; Cross Infection; Drug Therapy, Combination; Fatal Outcome; Human | 2014 |
Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Clindamycin; Female; Huma | 2015 |
Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiprotozoal Agents; CD4 Lymphocyte Cou | 2011 |
[Disseminated cerebral haemorrhages in a patient with HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral | 2011 |
Sulphadiazine-induced obstructive renal failure complicating treatment of HIV-associated toxoplasmosis.
Topics: Antiprotozoal Agents; Fluid Therapy; HIV Infections; Humans; Middle Aged; Nephrostomy, Percutaneous; | 2012 |
A healthy, 81-year-old woman with toxoplasmic encephalitis.
Topics: Aged, 80 and over; Antiprotozoal Agents; Diagnosis, Differential; Female; Humans; Pyrimethamine; Sul | 2012 |
Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosis.
Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Diagnosis, Differential; HIV-1; Humans; | 2012 |
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
Topics: Adult; Antiprotozoal Agents; Comorbidity; Disease Progression; Drug Therapy, Combination; Female; Gl | 2012 |
A solitary brain lesion in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Drug Therapy, Combination; Femal | 2003 |
Treatment of Toxoplasma brain abscess with clindamycin and sulfadiazine in an AIDS patient with concurrent atypical Pneumocystis carinii pneumonia.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain Abscess; Clindamycin; Drug Therapy, Combination; | 2002 |
Sulfadiazine-induced nephrolithiasis detected by spiral CT scan.
Topics: Adult; AIDS-Related Opportunistic Infections; Humans; Male; Sulfadiazine; Tomography, X-Ray Computed | 2004 |
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Brain Chemistry; Chromatography, High Pressure Liq | 2004 |
Cerebral toxoplasmosis in a patient with common variable immunodeficiency.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Protozoan; Antiprotozoal Agents; Biopsy; Brain; Central N | 2004 |
[Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Topics: Adolescent; Adult; Amniocentesis; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Chorioretini | 2005 |
[Renal failure caused by sulfadiazine in a HIV patient with toxoplasmic encephalitis].
Topics: Adult; Antiprotozoal Agents; Encephalitis; Female; HIV Infections; Humans; Sulfadiazine; Toxoplasmos | 2005 |
The case: 69 year old man with sand in the urine. N-acetylsulfadiazine crystals.
Topics: Acute Kidney Injury; Aged; Crystallization; Humans; Male; Sulfadiazine; Tomography, X-Ray Computed; | 2007 |
The timing of sulfadiazine therapy impacts the reactivation of latent Toxoplasma infection in IRF-8-/- mice.
Topics: Animals; Antiprotozoal Agents; Brain; Disease Models, Animal; Drug Administration Schedule; Humans; | 2007 |
[Acute renal failure due to sulfadiazine crystalluria].
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Alkalies; Animals; Antiprotozoal | 2007 |
Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiprotozoal Agents; Drug Ther | 2007 |
Drug treatment of toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Atovaquone; Clindamycin; Coccidiostats; Humans; Naphthoquinon | 1995 |
Toxoplasmosis in AIDS: keeping the lid on.
Topics: AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Encephalitis; Humans; Pyrimethamin | 1995 |
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Animals; Drug Resistance; Drug Therapy, Combination; Humans; Pyr | 1995 |
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
Topics: AIDS-Related Opportunistic Infections; Clindamycin; Dexamethasone; Drug Resistance, Microbial; Drug | 1995 |
Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS)
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Hemophilia A; Huma | 1994 |
Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Atrophy; Brain; Brain Abscess; Drug Therapy, Com | 1994 |
Cataplexy associated with midbrain lesion.
Topics: Adult; AIDS-Related Opportunistic Infections; Cataplexy; HIV Seropositivity; Humans; Magnetic Resona | 1995 |
Renal alterations induced by sulfadiazine therapy in an AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Female; Humans; Kidney Calc | 1994 |
[Sulfadiazine nephrolithiasis and nephropathy].
Topics: Adult; AIDS-Related Opportunistic Infections; Bicarbonates; Fluid Therapy; HIV Infections; Humans; H | 1994 |
Toxoplasma gondii infection in advanced HIV infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Encephalitis; Female; Humans; Male; Middle Ag | 1994 |
[Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Atovaquone; Clarithromycin; Clindamycin; Drug | 1994 |
[Recurrence of cerebral toxoplasmosis in 15 AIDS patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Clindamycin; Drug Therapy, Combination; Female; | 1994 |
Rifabutin is active in murine models of toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Clindamycin; Drug Therapy, Combination; Female; Mi | 1994 |
Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Antibodies, Protozoan; Drug Hypersensitivity; | 1993 |
[Drug-induced Stevens-Johnson syndrome in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Humans; Male; Middle Aged; Phenytoin; Pyrimethamine; Stevens-Joh | 1993 |
[Cerebral toxoplasmosis in AIDS. 73 cases. Clinical Epidemiology Group on AIDS in Aquitania].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Clarithromycin; Cl | 1993 |
[Acquired cerebral toxoplasmosis in an non-immunosuppressed child].
Topics: Child, Preschool; Drug Therapy, Combination; Female; Humans; Immunocompetence; Magnetic Resonance Im | 1993 |
Renal failure due to sulphadiazine in AIDS patients with cerebral toxoplasmosis.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Crystallization; Humans; Male; Su | 1993 |
Two central nervous system infectious diseases in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Hu | 1993 |
Symptomatic sulfadiazine crystalluria in AIDS patients: a report of two cases.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Drug Therapy, Combination; Humans | 1993 |
Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasmic encephalitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Clindamy | 1995 |
Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.
Topics: Animals; Anti-Infective Agents; Cytokines; Drug Synergism; Encephalitis; Female; Lymphocyte Activati | 1995 |
Folinic acid supplements to pyrimethamine-sulfadiazine for Toxoplasma encephalitis are associated with better outcome.
Topics: Antiprotozoal Agents; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Encephalitis; | 1996 |
Resolution of intracranial calcifications in infants with treated congenital toxoplasmosis.
Topics: Anti-Infective Agents; Brain; Calcinosis; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leucov | 1996 |
[Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Clind | 1996 |
[Acute renal insufficiency caused by a sulfadiazine in a patient with cerebral toxoplasmosis and AIDS].
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Humans; Ki | 1996 |
Precipitous visual loss secondary to optic nerve toxoplasmosis as an unusual presentation of AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therap | 1996 |
Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and Toxoplasma encephalitis.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Crystalliz | 1996 |
Use of rifabutin in combination with atovaquone, clindamycin, pyrimethamine, or sulfadiazine for treatment of toxoplasmic encephalitis in mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Brain; Clin | 1996 |
Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis.
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Athetosi | 1996 |
Clinical features, outcome and survival from cerebral toxoplasmosis in Edinburgh AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal | 1996 |
Acute renal failure due to sulphadiazine crystalluria in AIDS patients.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Crystalliz | 1996 |
Renal ultrasonic findings in sulphadiazine-induced renal failure.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Crystallization; Humans; Male; Mi | 1996 |
A clinical-parasitological monotherapy cure in the treatment of experimental infection by a highly virulent strain of Toxoplasma gondii.
Topics: Animals; Antiprotozoal Agents; Brain; Drug Evaluation, Preclinical; Drug Therapy, Combination; Mice; | 1996 |
Penetration of 3'-amino-3'-deoxythymidine, a cytotoxic metabolite of zidovudine, into the cerebrospinal fluid of HIV-1-infected patients.
Topics: Administration, Oral; Adult; Anti-HIV Agents; Anti-Infective Agents; Antidotes; Dideoxynucleosides; | 1997 |
[HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory | 1997 |
Toxoplasma encephalitis in a HIV patient: unusual involvement of the corpus callosum.
Topics: Adult; Animals; Anti-Infective Agents; Brain Neoplasms; Corpus Callosum; Diagnosis, Differential; En | 1997 |
[Cerebral toxoplasmosis and AIDS in Martinique].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Therapy, Combination; Fema | 1997 |
Neuropsychiatric lupus?
Topics: Anti-Infective Agents; Antibodies, Protozoan; Drug Therapy, Combination; Humans; Lupus Erythematosus | 1998 |
Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Clindamycin; Female; Graft vs Host Diseas | 1998 |
[Desensitization with sulfadiazine in a patient with cerebral toxoplasmosis refractory to alternative treatment].
Topics: Adult; AIDS-Related Opportunistic Infections; Animals; Desensitization, Immunologic; Drug Eruptions; | 1998 |
[Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Brain Neoplasms; | 1998 |
Post-transplant cerebral toxoplasmosis diagnosed by magnetic resonance imaging.
Topics: Adult; Anti-Infective Agents; Bone Marrow Transplantation; Hodgkin Disease; Humans; Male; Pyrimetham | 1998 |
Determination of the inhibitory effect on Toxoplasma growth in the serum of AIDS patients during acute therapy for toxoplasmic encephalitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dr | 1998 |
Fatal Stevens-Johnson syndrome in an AIDS patient treated with sulfadiazine.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiprotozoal Agents; Fatal Outcome; Humans; Male; Steven | 1999 |
Obstructive nephropathy due to sulfa crystals in two HIV seropositive patients treated with sulfadiazine.
Topics: AIDS-Related Opportunistic Infections; Alkalies; Antiprotozoal Agents; Crystallization; Female; Flui | 1999 |
Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.
Topics: Adult; Animals; Antibodies, Protozoan; Clindamycin; Drug Therapy, Combination; Female; Hematopoietic | 2001 |
[Kidney failure caused by sulphadiazine in patients with toxoplasma encephalitis].
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Encephaliti | 2000 |
[Toxoplasma encephalitis in a previously healthy man].
Topics: Abattoirs; Antiprotozoal Agents; Drug Therapy, Combination; Encephalitis; Humans; Male; Middle Aged; | 1999 |
Empiric treatment of acute Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Encephalitis; Humans; Pyrimethamine; Sulfadiazine; Toxoplasmo | 1992 |
Encephalopathy and psychoses associated with sulfadiazine in two patients with AIDS and CNS toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Humans; Male; Psychoses, Substance-Induced; Sulfadiazine; | 1992 |
[Acute renal failure caused by sulfadiazine crystalluria in AIDS. An historical resurgent iatrogenic complication].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adult; Humans; Iatrogenic Disease; Male; Op | 1992 |
Transitory alexia without agraphia in an HIV-positive patient suffering from toxoplasma encephalitis: a case report.
Topics: Adult; Agraphia; Drug Therapy, Combination; Dyslexia, Acquired; HIV Seropositivity; Humans; Leucovor | 1992 |
[Acute kidney failure due to sulfadiazine in the treatment of cerebral toxoplasmosis].
Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; HIV-1; Humans; Male; Middle Aged; Opportuni | 1992 |
Pyrimethamine alone as maintenance therapy for central nervous system toxoplasmosis in 38 patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Drug Therapy, Combination; Female; Humans; Male; Opportun | 1992 |
Sulphadiazine desensitization in AIDS patients.
Topics: Acquired Immunodeficiency Syndrome; Desensitization, Immunologic; Female; Humans; Male; Sulfadiazine | 1991 |